Targeted genetic manipulations of neuronal subtypes using promoter-specific combinatorial AAVs in wild-type animals

• Published in: Frontiers in behavioral neuroscience Vol. 9; p. 152
• Main Authors: Gompf, Heinrich S, Budygin, Evgeny A, Fuller, Patrick M, Bass, Caroline E
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Research Foundation 02.07.2015; Frontiers Media S.A
• Subjects: Adeno-associated virus; Arousal; Brain; c-Fos protein; Cocaine; Cytomegalovirus; Dopamine; EEG; Expression vectors; Gene expression; Genes; Genetic engineering; Hydroxylase; Immunohistochemistry; Locus coeruleus; Medical research; Neostriatum; Neurons; Neuroscience; Neurosciences; Promoters; Recombinase; Rodents; Sleep and wakefulness; Transgenic mice; Tyrosine 3-monooxygenase; Ventral tegmentum; Viruses; United States > US; dual AAV targeting; chemogenetic; locus coeruleus (LC); optogenetic; DREADD; tyrosine hydroxylase (TH); wild-type; ventral tegmental area (VTA)
• DOI: 10.3389/fnbeh.2015.00152
• ISSN: 1662-5153

Techniques to genetically manipulate the activity of defined neuronal subpopulations have been useful in elucidating function, however applicability to translational research beyond transgenic mice is limited. Subtype targeted transgene expression can be achieved using specific promoters, but often currently available promoters are either too large to package into many vectors, in particular adeno-associated virus (AAV), or do not drive expression at levels sufficient to alter behavior. To permit neuron subtype specific gene expression in wildtype animals, we developed a combinatorial AAV targeting system that drives, in combination, subtype specific Cre-recombinase expression with a strong but non-specific Cre-conditional transgene. Using this system we demonstrate that the tyrosine hydroxylase promoter (TH-Cre-AAV) restricted expression of channelrhodopsin-2 (EF1α-DIO-ChR2-EYFP-AAV) to the rat ventral tegmental area (VTA), or an activating DREADD (hSyn-DIO-hM3Dq-mCherry-AAV) to  the  rat  locus  coeruleus  (LC). High expression levels were achieved in both regions. Immunohistochemistry (IHC) showed the majority of ChR2+ neurons (>93%) colocalized with TH in the VTA, and optical stimulation evoked striatal dopamine release. Activation of TH neurons in the LC produced sustained EEG and behavioral arousal. TH-specific hM3Dq expression in the LC was further compared with: (1) a Cre construct driven by a strong but non-specific promoter (non-targeting); and (2) a retrogradely-transported WGA-Cre delivery mechanism (targeting a specific projection). IHC revealed that the area of c-fos activation after CNO treatment in the LC and peri-LC neurons appeared proportional to the resulting increase in wakefulness (non-targeted > targeted > ACC to LC projection restricted). Our dual AAV targeting system effectively overcomes the large size and weak activity barrier prevalent with many subtype specific promoters by functionally separating subtype specificity from promoter strength.